Reportable Segment — Total Assets
Business Segments · Total AssetsEli Lilly Reportable Segment — Total Assets increased by 13.9% to $114.94B in Q3 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ3 2025
Rolls up toTotal Assets
How to read this metric
Growth in assets relative to revenue may indicate capital-intensive expansion or potential inefficiencies in asset utilization.
Detailed definition
Represents the total value of all assets, including property, plant, equipment, inventory, and intangibles, that are dir...
Peer comparison
Standard metric for assessing segment-level capital deployment across the pharmaceutical sector.
Metric ID:
lly_segment_reportable_segment_total_assetsHistorical Data
5 periods
| Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|
| Value | $64.01B | $78.71B | $89.39B | $100.92B | $114.94B |
| QoQ Change | — | +23.0% | +13.6% | +12.9% | +13.9% |
| YoY Change | — | +23.0% | — | — | — |
Range$64.01B – $114.94B
CAGR+79.6%
Avg YoY Growth+23.0%
Median YoY Growth+23.0%
Current Streak4+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's reportable segment — total assets?
- Eli Lilly (LLY) reported reportable segment — total assets of $114.94B in Q3 2025.
- What does reportable segment — total assets mean?
- The total value of all assets owned and used by this specific business segment.